Currently, access to Wegovy on the NHS remains limited due to supply constraints and eligibility criteria, and similar considerations may apply to Retatrutide initially
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
The lever they offer in return is a 30% off first month promo (code Shed10, auto-applied through this link) which softens the unknown
CrossRef Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway Yongfei He, Qiang Tao, Shutian Mo, Meifeng Chen, Jicai Wang, Hang Zhai, Shengjie Hong, Qiang Gao, Guangquan Zhang, Chuangye Han, Xianjie Shi Frontiers in Oncology .2025;[Epub] CrossRef The use of durvalumab and tremelimumab after atezolizumab and bevacizumab in patients with hepatocellular carcinoma: case report and literature review Maen Abdelrahim, Abdullah Esmail Immunotherapy .2025
